The recent Semaglutide Cardiovascular Outcomes Trial (SOUL) reported that once-daily oral semaglutide (maximal dose, 14 mg), in addition to standard care, significantly reduces the risk of MACE in individuals with type 2 diabetes and atherosclerotic cardiovascular disease, chronic kidney disease, or both, without an increase in the incidence of serious adverse events [6]
For GLP-1 prescriptions filled through Edens network, your first package may include: Your prescribed medication (FDA-approved or compounded, as determined by your provider and insurance options) Injection supplies (needles and alcohol swabs), when applicable Detailed instruction guides for self-administration A disposal container for used needles New users get access to video tutorials that show proper injection technique
These medications utilize the GLP-1 pathway to suppress appetite, enhance feelings of fullness, and facilitate sustainable weight loss
When can I increase my dose
It is administered once weekly through a subcutaneous injection